Prohibition Partners · Free weekly briefing
International Cannabis Weekly
The week’s global cannabis news, read through the analyst’s lens — one sentence per story, sourced.
67
7 regions31 stories15 countries
Europe
10 stories- Lithuanian parliament votes to legalise medicinal cannabis use
LTRegulationlink no longer available
- Wayland signs a 9,000kg supply agreement to export cannabis to Germany
DEBusiness & Investmentlink no longer available
- Alpha-Cannabis Germany sells 25% stake to Organigram Holdings
DEBusiness & Investmentlink no longer available
- Nine notable figures who are leading the European cannabis space
Events & Industrylink no longer available
- Industry leaders to convene in Frankfurt at capital market conference
Events & Industrylink no longer available
- UK campaigners encourage medical cannabis access for all conditions
GBMedicallink no longer available
- Jersey publishes new legislation for prescribing medical cannabis
JERegulationlink no longer available
- The UK should emulate Canada and legalise cannabis for all uses
GBAdult-uselink no longer available
- New French Minister of the Interior supports cannabis reform
FRRegulationlink no longer available
- Prohibition Partners is presenting at IC3 in New York and 3CM in Frankfurt
Events & Industrylink no longer available
United States
2 stories- iAnthus and MPX Bioceutical announce merger
USBusiness & Investmentlink no longer available
- Canopy Growth purchases US hemp researcher Evergreen
USBusiness & Investmentlink no longer available
Canada
5 stories- Canada legalises cannabis for recreational adult use
CAAdult-uselink no longer available
- Canadian cannabis legalisation will affect countries across the world
CARegulationlink no longer available
- How the first day of legal cannabis unfolded in Canada
CAAdult-uselink no longer available
- Canadian cannabis companies experience shortages in wake of October 17th
CABusiness & Investmentlink no longer available
- Aphria intends to list on the New York Stock Exchange
CABusiness & Investmentlink no longer available
LATAM & Caribbean
5 stories- Latin America has the potential to become the largest cannabis supplier in the world
Business & Investmentlink no longer available
- Aphria completes first shipment of cannabis oil for clinical study in Argentina
ARMedicallink no longer available
- The Green Organic Dutchman and LLACA Grupo enter a joint venture in Mexico
MXBusiness & Investmentlink no longer available
- Support for cannabis decriminalisation is growing across the Caribbean
Regulationlink no longer available
- Saint Lucia Labour Party pushes for the legalisation of medical cannabis
LCRegulationlink no longer available
Africa & Middle East
2 stories- Cronos partners with Israel's Technicon to develop cannabinoid skincare
ILBusiness & Investmentlink no longer available
- Together Pharma is developing cannabis growth facilities in Uganda
UGBusiness & Investmentlink no longer available
Oceania
3 stories- New Zealand Health Ministry working towards a 2020 date for legal medical cannabis
NZMedicallink no longer available
- Australian politics are inhibiting the burgeoning cannabis industry
AURegulationlink no longer available
- Bod Australia is trialling sublingual cannabis wafers to deliver CBD
AUMedicallink no longer available
Rest of world
1 story- Facebook is removing the ban on cannabis and cannabis-related search results
Business & Investmentlink no longer available
Health & Science
- Companies rush to patent genetically modified cannabis molecules
Health & Sciencelink no longer available
- Israeli lab set up to give clinical validation to cannabis research
ILHealth & Sciencelink no longer available
- Spanish study finds more evidence that cannabis eases the symptoms of MS
ESHealth & Sciencelink no longer available
Never miss an issue
International Cannabis Weekly in your inbox every week — the global developments that move the market, with the data behind them.
From the research library
Global Medical Cannabis Market Review
14 key international markets, 2025–2030. Sizing, forecasts and regulatory outlook.
From £1,265
View report